Search details
1.
Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis.
Blood
; 137(4): 556-568, 2021 01 28.
Article
in English
| MEDLINE | ID: mdl-33104215
2.
Engaging hematopoietic cell transplantation patients and caregivers in the design of print and mobile application individualized survivorship care plan tools.
Support Care Cancer
; 28(6): 2805-2816, 2020 Jun.
Article
in English
| MEDLINE | ID: mdl-31729567
3.
Information Needs for Treatment Decision-making of Hematopoietic Cell Transplant Patients 65 Years or Older and Caregivers.
J Cancer Educ
; 35(4): 651-660, 2020 08.
Article
in English
| MEDLINE | ID: mdl-30877651
4.
Tailoring a Survivorship Care Plan: Patient and Provider Preferences for Recipients of Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(3): 562-569, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30315940
5.
Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors.
Haematologica
; 104(5): 1084-1092, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30514795
6.
Addressing Knowledge Gaps in Acute Myeloid Leukemia to Improve Referral for Hematopoietic Cell Transplantation Consultation.
J Natl Compr Canc Netw
; 17(12): 1473-1481, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31805525
7.
Caregiver availability and patient access to hematopoietic cell transplantation: social worker perspectives inform practice.
Support Care Cancer
; 27(11): 4253-4264, 2019 Nov.
Article
in English
| MEDLINE | ID: mdl-30850889
8.
Challenges around Access to and Cost of Life-Saving Medications after Allogeneic Hematopoietic Cell Transplantation for Medicare Patients.
Biol Blood Marrow Transplant
; 23(8): 1387-1392, 2017 Aug.
Article
in English
| MEDLINE | ID: mdl-28412517
9.
Healthcare Costs and Utilization for Patients Age 50 to 64 Years with Acute Myeloid Leukemia Treated with Chemotherapy or with Chemotherapy and Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 23(6): 1021-1028, 2017 Jun.
Article
in English
| MEDLINE | ID: mdl-28263920
10.
Administrative Claims Data for Economic Analyses in Hematopoietic Cell Transplantation: Challenges and Opportunities.
Biol Blood Marrow Transplant
; 22(10): 1738-1746, 2016 10.
Article
in English
| MEDLINE | ID: mdl-27184624
11.
Patient housing barriers to hematopoietic cell transplantation: results from a mixed-methods study of transplant center social workers.
Support Care Cancer
; 24(3): 1167-74, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-26275767
12.
Designing and operationalizing a customized internal evaluation model for cancer treatment support programs.
J Cancer Educ
; 29(3): 463-72, 2014 Sep.
Article
in English
| MEDLINE | ID: mdl-24756544
13.
Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipients.
Blood Adv
; 8(4): 1002-1017, 2024 Feb 27.
Article
in English
| MEDLINE | ID: mdl-38127268
14.
Trends in Volumes and Survival After Hematopoietic Cell Transplantation in Racial/Ethnic Minorities.
Blood Adv
; 2024 Apr 25.
Article
in English
| MEDLINE | ID: mdl-38661372
15.
Reducing barriers of access and care related to hematopoietic cell transplantation and cellular therapy: The mission-driven role of the national marrow donor program.
Best Pract Res Clin Haematol
; 36(2): 101480, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37353289
16.
Impact of Public Reporting of Center-Specific Survival Analysis Scores on Patient Volumes at Hematopoietic Cell Transplant Centers.
Transplant Cell Ther
; 29(8): 523-528, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37220838
17.
Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.
Transplant Cell Ther
; 29(6): 388.e1-388.e6, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36870388
18.
Critical Illness Risk and Long-Term Outcomes Following Intensive Care in Pediatric Hematopoietic Cell Transplant Recipients.
medRxiv
; 2023 Aug 05.
Article
in English
| MEDLINE | ID: mdl-37577706
19.
Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis.
Blood Adv
; 7(22): 6830-6838, 2023 11 28.
Article
in English
| MEDLINE | ID: mdl-37773924
20.
Health-Related Quality of Life Outcomes in Older Hematopoietic Cell Transplantation Survivors.
Transplant Cell Ther
; 29(3): 202.e1-202.e8, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36427784